Hints and tips:
Related Special Reports
...This month Brazil started distributing a vaccine produced by Japanese pharmaceutical group Takeda....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Until this year, the biggest obesity deal was worth up to $185mn, when Japan’s Takeda Pharmaceuticals sold the US rights to the weight loss drug Contrave to California-based Orexigen Therapeutics in 2016...
...Michael Lohan said Ireland was poised to win several big investments from pharmaceutical and medical device companies attracted to the country’s blend of tax incentives, political stability, skilled workforce...
...Instead, Isomorphic chose to sign deals with just two pharmaceutical companies....
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
...The leader of the pack was Teva Pharmaceuticals, whose market capitalisation reached $60bn in 2015. Teva now sits in the crosshairs of law enforcement....
...Packaged food companies have built strong and trusted brands over decades....
...The UK pharmaceutical retailer’s transfer of £4.8bn of pension obligations to insurer Legal & General brings its potential sale by owner Walgreens Boots Alliance one step closer....
...The latest £200mn project was a collaboration funded by the government, Wellcome Trust, Britain’s biggest biomedical charity, and four pharmaceutical companies....
Using AI should speed up detection of diseases caused by genetic variants but it does not guarantee success
...A chunky acquisition is needed to get growth up and build a company able to tackle larger, later-stage trials....
...But until recently, many large pharmaceutical companies were reluctant to invest heavily in finding treatments after decades of failure....
...The company — founded as a specialist AI developer in 2010 and bought by Google in 2014 — has made the tool “freely available to the scientific community”....
...But he warned it was proving difficult for the company to turn that into financial returns....
...In the second quarter of 2023 the FTSE All-Share pharmaceutical and biotechnology price return index closed 13 per cent higher than the FTSE All Share price return index....
...As in publishing and other industries, the early nurturing of talent is often left to smaller firms, with big companies waiting for winners to emerge....
...An executive at Takeda tells Edmondson that instead of celebrating failure, which “implies a . . . bad ending”, the Japanese pharmaceutical company likes to celebrate when it pivots....
...Takeda has said approval of its dengue fever vaccine in Indonesia marks a big step towards the company’s goal of creating a global vaccine business that would compete with larger rivals such as GSK, Sanofi...
...The company said it would wait to see details of the registry before it finalises spending plans to support rollout of the drug....
...It comes after decades during which many big pharmaceutical companies lost hope and cut investment in Alzheimer’s research....
...Pharmaceutical companies including AstraZeneca and Johnson and Johnson already work with the UK Biobank to access genomic data....
...It also generated excitement across the pharmaceutical industry, which is enticed by the prospect of selling medicines to the more than 50mn people worldwide who suffer from the disease....
...Over the past week, a clutch of Chinese pharmaceutical companies have been among the top performers on bourses in Hong Kong, Shanghai and Shenzhen....
...Vodafone on the deal, in addition to its gig advising Brookfield on its £2.2bn purchase of London-listed credit card processor Network International and EQT’s £4.5bn takeover of veterinary drugmaker Dechra Pharmaceuticals...
International Edition